Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 3 Active
-
Management of (activated) factor eleven (FXI(a)) inhibitors
Vassart, J. (Researcher), Douxfils, J. (PI) & Dogne, J.-M. (Co-supervisor)
17/10/22 → …
Project: PHD
-
Clinical Pharmacology Research Group
Douxfils, J. (Supervisor), Dogne, J.-M. (Supervisor), Musuamba Tshinanu, F. (Supervisor), Masereel, B. (Supervisor), Wieërs, G. (Supervisor), Haguet, H. (Researcher), RONVAUX, L. (Researcher), Donis, N. (Researcher), Morimont, L. (Researcher), Evrard, J. (Researcher), Siriez, R. (Researcher), Gillot, C. (Researcher), FAVRESSE, J. (Researcher), BOUVY, C. (Researcher), Djokoto, H. (Researcher), Didembourg, M. (Researcher), David, C. (Support role), Melchionda, S. (Support role), Maloteau, V. (Technician), Boucher, A.-Y. (Technician), Devel, P. (Technician), Modaffari, E. (Technician), Vandeputte, M. (Technician), De Messemaeker, A. (Secretaire), Decarpentrie, J. (Researcher), Vassart, J. (Researcher) & De Groote, A. (Researcher)
1/04/22 → …
Project: Research Axis
-
The BIOCOAG project : Biological assessment of the control of anticoagulation
Douxfils, J. (PI), Mullier, F. (CoI), Dogne, J.-M. (CoI), Siriez, R. (Researcher), Evrard, J. (Researcher) & Vassart, J. (Researcher)
1/09/11 → …
Project: Research
-
Accuracy of DOAC Dipstick urine test from patients treated peri-operatively with DOACs compared to UHPLC-MS/MS
Vassart, J., Boucher, A.-Y., Morimont, L., Tafur, A., Walenga, J., Harenberg, J. F. & Douxfils, J., 27 Feb 2024.Research output: Contribution to conference › Poster › peer-review
File11 Downloads (Pure) -
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An expert consensus paper
Harenberg, J., Gosselin, R. C., Cuker, A., Becattini, C., Pabinger, I., Poli, S., Weitz, J. I., Ageno, W., Bauersachs, R., Ćelap, I., Choi, P., Douketis, J., Douxfils, J., Elalamy, I., Fareed, J., Falanga, A., Favalor, E., Gerotziafas, G. T., Herkner, H. & Hetjens, S. & 17 others, , 5 Feb 2024, (E-pub ahead of print) In: Thrombosis and Haemostasis.Research output: Contribution to journal › Article › peer-review
Open AccessFile56 Downloads (Pure) -
Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?
Vassart, J., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Lebreton, A., Mullier, F., Donis, N., Favresse, J., Dogne, J.-M. & Douxfils, J., 7 Mar 2024, In: Thrombosis Research. 236, April 2024, p. 236-239 4 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile74 Downloads (Pure) -
Corrigendum to "Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?” [Thromb. Res. 236 (2024) 236–239 TR_8963, (S0049384824000732), (10.1016/j.thromres.2024.03.001)]
Vassart, J., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Lebreton, A., Mullier, F., Donis, N., Favresse, J., Dogné, J.-M. & Douxfils, J., Aug 2024, In: Thrombosis Research. 240, p. 109066 109066.Research output: Contribution to journal › Comment/debate › peer-review
-
The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative setting
Vassart, J., Tafur, A., Durante, M., Boucher, A.-Y., Morimont, L., Walenga, J., Harenberg, J. F. & Douxfils, J., Jul 2024, In: Thrombosis Research. 239, July 2024, 109023.Research output: Contribution to journal › Article › peer-review
Open Access
Activities
-
31st Annual Meeting of the Belgian Society on Thrombosis and Haemostasis (BSTH)
Vassart, J. (Poster)
28 Nov 2024 → 29 Nov 2024Activity: Participating in or organising an event types › Participation in conference
-
EuroThrombosis & Eurovessels 2024 - Asundexian and milvexian: What impact on the activity of the intrinsic pathway ?
Vassart, J. (Speaker)
12 Oct 2024Activity: Talk or presentation types › Oral presentation
-
EuroThrombosis & EuroVessels 2024
Vassart, J. (Participant)
10 Oct 2024 → 12 Oct 2024Activity: Participating in or organising an event types › Participation in conference
-
37th International Symposium on Technical Innovations in Laboratory Hematology of the International Society on Laboratory Hematology (ISLH)
Vassart, J. (Poster)
30 May 2024 → 1 Jun 2024Activity: Participating in or organising an event types › Participation in conference
-
37th International Symposium on Technical Innovations in Laboratory Hematology + EDUCATIONAL WORKSHOP: FOCUS ON COAGULATION
Vassart, J. (Participant)
29 May 2024 → 1 Jun 2024Activity: Participating in or organising an event types › Participation in workshop, seminar, course
Thesis
-
Rhodiola rosea L., un remède sûr et efficace dans la prise en charge du trouble dépressif majeur chez l'adulte ?
Vassart, J. (Author) Quetin-Leclercq, J. (Supervisor), 2022Student thesis: Master types › Master in Pharmaceutical Sciences, Professionnal focus
File